Are You at Risk? Identifying Blood Clot Danger in Cancer Patients

Published: May 19, 2024

Not all cancer patients face the same risk of developing blood clots. Understanding your personal risk factors can help you and your medical team take appropriate preventive measures.

Cancer-Related Risk Factors

The type and stage of cancer play a significant role in blood clot risk. Pancreatic, brain, and stomach cancers are associated with higher risks. Advanced or metastatic cancers also increase the likelihood of clots. The first year after diagnosis is a particularly high-risk period for most cancer types.

Treatment-Related Risks

Certain cancer treatments can elevate blood clot risk. Chemotherapy, especially platinum-based drugs, is a known risk factor. Some targeted therapies and hormonal treatments also increase risk. Major surgery, especially abdominal or pelvic procedures, significantly raises clot risk in the weeks following the operation.

Identifying and understanding the risk factors for developing blood clots in cancer patients, focusing on cancer-related and treatment-related risks.

Patient-Specific Factors

Individual characteristics can further influence clot risk. Older age, obesity, and a history of blood clots are important factors. Immobility, such as being bedridden or during long flights, increases risk. Certain inherited blood disorders can also make you more prone to clots. Discuss these factors with your doctor to get a complete risk assessment.

Frequently Asked Questions

Surprisingly, smoking doesn't significantly increase risk in cancer patients.

Yes, hospitalization greatly increases clot risk for cancer patients.

Some tests like D-dimer can help, but aren't definitive alone.

No, some types carry higher risk than others.

Key Takeaways

Understanding your personal risk factors empowers you to take proactive steps in preventing blood clots.

Talk to Doctronic about assessing your individual blood clot risk and creating a personalized prevention plan.

Related Articles

References

Khorana AA, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111:4902.

Pabinger I, et al. Biomarkers for prediction of venous thromboembolism in cancer. Blood 2013; 122:2011.

Always discuss health information with your healthcare provider.